Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies. - Wikidata - wikimedia - TriplyDB

Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies.

Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies.

http://www.wikidata.org/entity/Q37705263

about

Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway.Emodin ameliorates renal fibrosis in rats via TGF-β1/Smad signaling pathway and function study of Smurf 2.CD39-adenosinergic axis in renal pathophysiology and therapeutics.Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis.A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.Resolution of organ fibrosis.Mito-TEMPO Alleviates Renal Fibrosis by Reducing Inflammation, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress.Murine Nephrotoxic Nephritis as a Model of Chronic Kidney Disease.Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice.

P2860

Q47131483-DEAA2EEB-53E0-4D30-B311-381EBC43327F Q47303784-A41D717E-43B4-438E-AA3E-59489E8F128E Q47655859-31E6334D-1D83-407C-B865-7EAACC3DD4D6 Q49805700-0EA74C12-008A-460A-B9B2-00FA172462A3 Q50057516-2FB8CB9A-52DF-448E-A8EA-2D78D5DAD001 Q52687459-46A61BE4-9A00-499F-8E65-81301D44139C Q55331663-A637CF01-BFC0-461A-BE9C-ECD2D57F8BDD Q55344788-0B95D50C-DDAC-49D7-9CC3-8E5331702288 Q55359974-B32BCD5A-F501-4F9B-A145-29B5AF685370

P2860

Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies.

http://www.wikidata.org/entity/Q37705263

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pathophysiological Mechanisms ...... ls and Therapeutic Strategies.

@en

Pathophysiological Mechanisms ...... ls and Therapeutic Strategies.

@nl

type

label

Pathophysiological Mechanisms ...... ls and Therapeutic Strategies.

@en

Pathophysiological Mechanisms ...... ls and Therapeutic Strategies.

@nl

prefLabel

Pathophysiological Mechanisms ...... ls and Therapeutic Strategies.

@en

Pathophysiological Mechanisms ...... ls and Therapeutic Strategies.

@nl

P1433

Q37705263-DCBE704A-6AD5-42CC-9D52-FE89941E1C99

P1476

Q37705263-706D8467-8CD2-4558-9E8A-A5FD56297CCA

P2093

Q37705263-8926DFF4-A780-4345-8748-B20F69AB655D

Q37705263-B4BF988C-CD10-43A4-8647-A3D23AB782EA

Q37705263-E0C04313-2775-4397-8C70-F4B05BE81130

P2860

Q37705263-00CBCFE1-B2D2-4E78-811B-00B08F0C9152

Q37705263-07F6AFD4-9083-48FF-9DE1-0C2C313B487B

Q37705263-0B081153-003A-4DE9-939A-08084C64F3B2

Q37705263-0B17D23D-AF26-4310-94BF-D0B2F626B057

Q37705263-0B8B559F-DB49-42DC-AF51-66BD9434E352

Q37705263-0D0259E4-2720-49C7-97C0-D49A3B1C0FC7

Q37705263-0EEC11D7-A571-42A4-8FE6-CA1B9D407A7A

Q37705263-11AC82C4-95CD-4C25-A4D5-6F5E7C347AB7

Q37705263-17D68895-D3C0-4165-A5CC-7E9A64607503

Q37705263-18E8A212-7104-4354-8AFE-51604DAD345F

P304

Q37705263-3D29ADFC-D167-4DC0-9AD1-ADF8BB0DCC46

P31

Q37705263-C7CD50EF-DFA0-4588-BD87-9C16031F8DFC

P356

Q37705263-2F1C6989-53C4-4FB1-936D-EA0389DC8186

P433

Q37705263-6915336F-C641-4132-9B80-0FA19F0DB3F0

P478

Q37705263-52CF0BE2-DF9A-46DB-8B88-2E0ADA1C171D

P50

Q37705263-35A58CFE-1461-4821-8A25-3C1F26A4A8C7

Q37705263-97E193A5-4AC0-46A0-8CF2-0A97AD8CD307

Q37705263-DB8AA909-B0D3-4E24-842C-88C8324EF776

P577

Q37705263-B5EA860C-1011-4A9E-8114-30B1D3681C93

P698

Q37705263-B9957078-1321-4581-AC29-9116083D287C

P921

Q37705263-74786B66-B191-46FE-BB90-62532133A959

P932

Q37705263-9C453E94-BF21-4B56-A23A-CB38A27D10F0

P356

P1433

P1476

Pathophysiological Mechanisms ...... ls and Therapeutic Strategies.

@en

P2093

António Nogueira

http://www.w3.org/2001/XMLSchema#string

Maria João Pires

http://www.w3.org/2001/XMLSchema#string

Paula Alexandra Oliveira

http://www.w3.org/2001/XMLSchema#string

P2860

Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats

Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3

Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat

Function and activation of NF-kappa B in the immune system

Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events.

P304

1-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21873/INVIVO.11019

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Paula A. Oliveira

Maria João Pires

António Nogueira

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28064215

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

5354133

http://www.w3.org/2001/XMLSchema#string